EYPT

EYPT

USD

EyePoint Pharmaceuticals Inc. Common Stock

$12.390+0.260 (2.143%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$12.130

High

$12.950

Low

$11.960

Volume

4.59M

Company Fundamentals

Market Cap

1.0B

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

1.08M

Exchange

NGM

Currency

USD

52-Week Range

Low $3.91Current $12.390High $14.91

Related News

GlobeNewswire

EyePoint Announces Pricing of Public Offering

WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with

View more
EyePoint Announces Pricing of Public Offering
GlobeNewswire

EyePoint Announces Proposed Public Offering of Common Stock

WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with

View more
EyePoint Announces Proposed Public Offering of Common Stock
GlobeNewswire

EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema

– DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New preclinical data

View more
EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema